drugset / Trial / NCT02621268

Minimally Invasive Imagery With Indocyanine Green

NCT02621268

Phase 1 Completed 48 enrolled University of Pennsylvania
NaSingle-groupOpen-labelDiagnostic

Summary

Determine if ICG administered pre-operatively, then imaged intraoperatively using our cameras, will aid in the identification of a suspected thoracic nodules, margins, lymph nodes and satellite nodules during minimally invasive procedures. The investigators intend on enrolling 48 Subjects in this study. The study is focusing on patients presenting with suspected thoracic cancers who are considered to be good minimally invasive surgical candidates

Timeline

Start
2014-11
Primary completion
2016-11
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent 5 mg/kg Intravenous

Indications